PMID- 28273173 OWN - NLM STAT- MEDLINE DCOM- 20170825 LR - 20190208 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 12 IP - 3 DP - 2017 TI - Relationships between lifestyle patterns and cardio-renal-metabolic parameters in patients with type 2 diabetes mellitus: A cross-sectional study. PG - e0173540 LID - 10.1371/journal.pone.0173540 [doi] LID - e0173540 AB - INTRODUCTION: While individuals tend to show accumulation of certain lifestyle patterns, the effect of such patterns in real daily life on cardio-renal-metabolic parameters remains largely unknown. This study aimed to assess clustering of lifestyle patterns and investigate the relationships between such patterns and cardio-renal-metabolic parameters. PARTICIPANTS AND METHODS: The study participants were 726 Japanese type 2 diabetes mellitus (T2DM) outpatients free of history of cardiovascular diseases. The relationship between lifestyle patterns and cardio-renal-metabolic parameters was investigated by linear and logistic regression analyses. RESULTS: Factor analysis identified three lifestyle patterns. Subjects characterized by evening type, poor sleep quality and depressive status (type 1 pattern) had high levels of HbA1c, alanine aminotransferase and albuminuria. Subjects characterized by high consumption of food, alcohol and cigarettes (type 2 pattern) had high levels of gamma-glutamyl transpeptidase, triglycerides, HDL-cholesterol, blood pressure, and brachial-ankle pulse wave velocity. Subjects characterized by high physical activity (type 3 pattern) had low uric acid and mild elevation of alanine aminotransferase and aspartate aminotransferase. In multivariate regression analysis adjusted by age, gender and BMI, type 1 pattern was associated with higher HbA1c levels, systolic BP and brachial-ankle pulse wave velocity. Type 2 pattern was associated with higher HDL-cholesterol levels, triglycerides, aspartate aminotransferase, ɤ- glutamyl transpeptidase levels, and diastolic BP. CONCLUSIONS: The study identified three lifestyle patterns that were associated with distinct cardio-metabolic-renal parameters in T2DM patients. TRIAL REGISTRATION: UMIN000010932. FAU - Ogihara, Takeshi AU - Ogihara T AD - Department of Metabolism & Endocrinology, Tokyo, Japan. FAU - Mita, Tomoya AU - Mita T AUID- ORCID: 0000-0002-4401-2965 AD - Department of Metabolism & Endocrinology, Tokyo, Japan. AD - Center for Therapeutic Innovations in Diabetes, Tokyo, Japan. FAU - Osonoi, Yusuke AU - Osonoi Y AD - Department of Metabolism & Endocrinology, Tokyo, Japan. FAU - Osonoi, Takeshi AU - Osonoi T AD - Naka Memorial Clinic, Naka City, Ibaraki, Japan. FAU - Saito, Miyoko AU - Saito M AD - Naka Memorial Clinic, Naka City, Ibaraki, Japan. FAU - Tamasawa, Atsuko AU - Tamasawa A AD - Naka Memorial Clinic, Naka City, Ibaraki, Japan. FAU - Nakayama, Shiho AU - Nakayama S AD - Department of Metabolism & Endocrinology, Tokyo, Japan. FAU - Someya, Yuki AU - Someya Y AD - Department of Metabolism & Endocrinology, Tokyo, Japan. FAU - Ishida, Hidenori AU - Ishida H AD - Naka Memorial Clinic, Naka City, Ibaraki, Japan. FAU - Gosho, Masahiko AU - Gosho M AD - Department of Clinical Trial and Clinical Epidemiology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan. FAU - Kanazawa, Akio AU - Kanazawa A AD - Department of Metabolism & Endocrinology, Tokyo, Japan. AD - Center for Therapeutic Innovations in Diabetes, Tokyo, Japan. FAU - Watada, Hirotaka AU - Watada H AD - Department of Metabolism & Endocrinology, Tokyo, Japan. AD - Center for Therapeutic Innovations in Diabetes, Tokyo, Japan. AD - Center for Molecular Diabetology, Tokyo, Japan. AD - Sportology Center, Juntendo University Graduate School of Medicine, Tokyo, Japan. LA - eng PT - Journal Article DEP - 20170308 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Biomarkers) SB - IM MH - Adult MH - Aged MH - Biomarkers MH - Cardiovascular Diseases/*complications/*metabolism MH - Cross-Sectional Studies MH - Diabetes Mellitus, Type 2/*epidemiology/*etiology MH - Female MH - Humans MH - Japan/epidemiology MH - Kidney Diseases/*complications/*metabolism MH - *Life Style MH - Male MH - Middle Aged MH - Risk Factors MH - Surveys and Questionnaires PMC - PMC5342268 COIS- Competing Interests: H.W. has received lecture fees from Boehringer Ingelheim, Sanofi-Aventis, Ono Pharmaceutical Co., Novo Nordisk Pharma, Novartis Pharmaceuticals, Eli Lilly, Sanwakagaku Kenkyusho, Daiichi Sankyo Inc., Takeda Pharmaceutical Co., MSD, Dainippon Sumitomo Pharm., Kowa Co. and research funds from Boehringer Ingelheim, Pfizer, Mochida Pharmaceutical Co., Sanofi-Aventis, Novo Nordisk Pharma, Novartis Pharmaceuticals, Sanwakagaku Kenkyusho, Terumo Corp. Eli Lilly, Mitsubishi Tanabe Pharma, Daiichi Sankyo Inc., Takeda Pharmaceutical Co., MSD, Shionogi, Pharma, Dainippon Sumitomo Pharma, Kissei Pharma, and Astrazeneca. Other authors have no conflicting interests. This does not alter our adherence to PLOS ONE policies on sharing data and materials. EDAT- 2017/03/09 06:00 MHDA- 2017/08/26 06:00 PMCR- 2017/03/08 CRDT- 2017/03/09 06:00 PHST- 2016/12/24 00:00 [received] PHST- 2017/02/22 00:00 [accepted] PHST- 2017/03/09 06:00 [entrez] PHST- 2017/03/09 06:00 [pubmed] PHST- 2017/08/26 06:00 [medline] PHST- 2017/03/08 00:00 [pmc-release] AID - PONE-D-16-50889 [pii] AID - 10.1371/journal.pone.0173540 [doi] PST - epublish SO - PLoS One. 2017 Mar 8;12(3):e0173540. doi: 10.1371/journal.pone.0173540. eCollection 2017.